Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SUSAN DENT

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1912482498
CMS profile
5694902
Location
ROCHESTER, NY

General Payments · PY2018–2024

$134,456.28

  • Reported across 105 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$18,004.97

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $465.58 3
PY2019 $4,859.81 16
PY2020 $17,383.04 18
PY2021 $4,918.15 10
PY2022 $39,896.61 17
PY2023 $48,928.12 26
PY2024 $18,004.97 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $31.64 06/01/2024 Food and Beverage Undisputed 01/23/2026 1104542856 CMS
Daiichi Sankyo Inc. $25.38 06/01/2024 Food and Beverage Undisputed 01/23/2026 1089414956 CMS
Gilead Sciences, Inc. $125.00 12/10/2024 Food and Beverage Undisputed 01/23/2026 1133829491 CMS
Merck Sharp & Dohme LLC $96.83 03/13/2024 Food and Beverage Undisputed 01/23/2026 1141659383 CMS
Myocardial Solutions, Inc. $3,500.00 03/26/2024 Honoraria Undisputed 01/23/2026 1137311864 CMS
Myocardial Solutions, Inc. $245.43 09/21/2024 Food and Beverage Undisputed 01/23/2026 1137302148 CMS
Novartis Pharmaceuticals Corporation $5,750.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1086958719 CMS
Novartis Pharmaceuticals Corporation $29.16 12/12/2024 Food and Beverage Undisputed 01/23/2026 1086958721 CMS
PFIZER INC. $1,575.00 01/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131443377 CMS
PFIZER INC. $2,520.00 06/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131499966 CMS
PFIZER INC. $70.26 12/12/2024 Food and Beverage Undisputed 01/23/2026 1131596888 CMS
Stemline Therapeutics Inc. $191.75 08/20/2024 Food and Beverage Undisputed 01/23/2026 1142964890 CMS
Stemline Therapeutics Inc. $47.51 08/22/2024 Food and Beverage Undisputed 01/23/2026 1142964897 CMS
Stemline Therapeutics Inc. $97.01 08/24/2024 Food and Beverage Undisputed 01/23/2026 1142964894 CMS
WHITEHALL INTERNATIONAL INC $3,700.00 03/20/2024 Consulting Fee Undisputed 01/23/2026 1131494383 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.